Consensus Intuitive Surgical, Inc.

Equities

ISRG

US46120E6023

Market Closed - Nasdaq 04:00:00 2024-02-26 pm EST 5-day change 1st Jan Change
388.3 USD -0.38% Intraday chart for Intuitive Surgical, Inc. +2.55% +15.09%

Evolution of the average Target Price on Intuitive Surgical, Inc.

Price target over the last 5 years

History of analyst recommendation changes

51c80ed6.59mEqxrcsGJKn4avkt4fKOBXcIi_-NWD7kZ1CaN-HiU.0bXH4yLk9ld-st6ao71YX6RlRPn1gr_tuzMUXtkNT0Om7uLOXb__Vy37zw~d0fbb4192fdd97f7bba919a0d54e6883
ANALYST RECOMMENDATIONS : Abbvie, Microsoft, Tesla, Alphabet, Booking... Our Logo
Which Jerome will we get? Our Logo
ANALYST RECOMMENDATIONS : GM, Verizon, Fortinet, Microsoft, AMD... Our Logo
Raymond James Raises Price Target on Intuitive Surgical to $435 From $372, Keeps Outperform Rating MT
Citigroup Raises Price Target on Intuitive Surgical to $428 From $390, Keeps Buy Rating MT
Evercore ISI Adjusts Price Target on Intuitive Surgical to $385 From $335, Keeps In Line Rating MT
Baird Raises Price Target on Intuitive Surgical to $440 From $380, Keeps Outperform Rating MT
Mizuho Adjusts Price Target on Intuitive Surgical to $390 From $350, Keeps Neutral Rating MT
Stifel Adjusts Price Target on Intuitive Surgical to $420 From $360, Maintains Buy Rating MT
Deutsche Bank Adjusts Intuitive Surgical Price Target to $370 From $275, Maintains Hold Rating MT
Truist Securities Increases Price Target on Intuitive Surgical to $435 From $390, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on Intuitive Surgical to $375 From $330, Maintains Equal-Weight Rating MT
Barclays Hikes Price Target on Intuitive Surgical to $430 From $385, Maintains Overweight Rating MT
BTIG Raises Price Target on Intuitive Surgical to $412 From $392, Maintains Buy Rating MT
JPMorgan Raises Price Target on Intuitive Surgical to $475 From $325, Maintains Overweight Rating MT
Piper Sandler Raises Intuitive Surgical Price Target to $425 From $325, Maintains Overweight Rating MT
RBC Raises Price Target on Intuitive Surgical to $432 From $400, Sees 'Substantial Upside Potential' Ahead, Keeps Outperform Rating MT
ANALYST RECOMMENDATIONS : Accenture, AMD, Easyjet, Fortinet, Netflix... Our Logo
UBS Raises Intuitive Surgical Price Target to $385 From $316, Maintains Neutral Rating MT
Wells Fargo Raises Price Target on Intuitive Surgical to $416 From $363, Maintains Overweight Rating MT
RBC Raises Price Target on Intuitive Surgical to $400 From $380, Keeps Outperform Rating MT
Raymond James Raises Price Target on Intuitive Surgical to $372 From $310, Maintains Outperform Rating MT
Truist Securities Raises Price Target on Intuitive Surgical to $390 From $375, Maintains Buy Rating MT
ANALYST RECOMMENDATIONS : Amgen, Eli Lilly, Micron Salesforce, Texas Instruments... Our Logo
ANALYST RECOMMENDATIONS : Adobe, Blackrock, Roblox, Snap, US Bancorp... Our Logo
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
388.3 USD
Average target price
408.5 USD
Spread / Average Target
+5.20%
High Price Target
475 USD
Spread / Highest target
+22.34%
Low Price Target
230 USD
Spread / Lowest Target
-40.76%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Intuitive Surgical, Inc.

Raymond James
Citigroup
Evercore ISI
Baird
Mizuho Securities
Stifel Nicolaus
Deutsche Bank Securities
Truist Securities
Morgan Stanley
Barclays
BTIG
JPMorgan Chase
Piper Sandler
RBC Capital Markets
UBS
Wells Fargo Securities
Argus
Morningstar
Bernstein
Jefferies & Co.
BofA Securities
William Blair & Co.
Goldman Sachs
Wolfe Research
Redburn
SVB Leerink
J.P. Morgan Chase
Oppenheimer
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW